LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

LLY

738.06

+1.61%↑

JNJ

178.12

-0.03%↓

ABBV

209.99

-1.09%↓

UNH

320.2

+1.63%↑

NVO

54.31

-1.47%↓

Search

Bruker Corp

Closed

SectorHealthcare

30.77 -0.13

Overview

Share price change

24h

Current

Min

29.77

Max

31.04

Key metrics

By Trading Economics

Income

-13M

4.2M

Sales

-4M

797M

P/E

Sector Avg

65.346

35.733

EPS

0.47

Dividend yield

0.6

Profit margin

0.527

Employees

11,396

EBITDA

-166M

-77M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+52.12% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.60%

3.13%

Next Earnings

4 lis 2025

Next Dividend date

3 paź 2025

Next Ex Dividend date

23 wrz 2025

Market Stats

By TradingEconomics

Market Cap

-105M

5.2B

Previous open

30.9

Previous close

30.77

News Sentiment

By Acuity

50%

50%

173 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Bruker Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 wrz 2025, 22:10 UTC

Major Market Movers

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

Peer Comparison

Price change

Bruker Corp Forecast

Price Target

By TipRanks

52.12% upside

12 Months Forecast

Average 46.9 USD  52.12%

High 65 USD

Low 38 USD

Based on 10 Wall Street analysts offering 12 month price targets forBruker Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

6

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

38.97 / 40.73Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

173 / 371 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
help-icon Live chat